Daniel J. Brooks

5.0k total citations
98 papers, 2.8k citations indexed

About

Daniel J. Brooks is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Daniel J. Brooks has authored 98 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 24 papers in Oncology and 23 papers in Pharmacology. Recurrent topics in Daniel J. Brooks's work include Bone health and treatments (18 papers), Attention Deficit Hyperactivity Disorder (17 papers) and Cannabis and Cannabinoid Research (17 papers). Daniel J. Brooks is often cited by papers focused on Bone health and treatments (18 papers), Attention Deficit Hyperactivity Disorder (17 papers) and Cannabis and Cannabinoid Research (17 papers). Daniel J. Brooks collaborates with scholars based in United States, Australia and Canada. Daniel J. Brooks's co-authors include Frances R. Levin, John J. Mariani, Edward V. Nunes, Suzette M. Evans, Mary Bouxsein, Martina Pavlicová, Fatima Garawi, Amy L. Mahony, Wendy Y. Cheng and Glenda M. Halliday and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Daniel J. Brooks

94 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel J. Brooks United States 31 767 747 708 580 401 98 2.8k
José Luís Carrasco Spain 26 361 0.5× 294 0.4× 236 0.3× 132 0.2× 277 0.7× 127 2.2k
Peter Flachenecker Germany 30 749 1.0× 240 0.3× 178 0.3× 306 0.5× 155 0.4× 118 3.4k
Martin Marziniak Germany 32 1.2k 1.5× 317 0.4× 645 0.9× 461 0.8× 138 0.3× 85 3.7k
Ronaldo F. Enriquez Australia 30 198 0.3× 745 1.0× 145 0.2× 1.1k 1.9× 296 0.7× 55 3.0k
P. Bettica Italy 27 133 0.2× 823 1.1× 242 0.3× 195 0.3× 168 0.4× 76 2.5k
Nina Mononen Finland 30 232 0.3× 954 1.3× 206 0.3× 176 0.3× 282 0.7× 88 2.4k
Michael Knapp Germany 43 660 0.9× 1.9k 2.5× 175 0.2× 1.1k 1.8× 290 0.7× 147 5.2k
Marie D’hooghe Belgium 33 620 0.8× 328 0.4× 116 0.2× 109 0.2× 146 0.4× 107 3.3k
Mark B. Bromberg United States 41 261 0.3× 1.2k 1.6× 215 0.3× 1.3k 2.3× 229 0.6× 169 5.8k
Giovanni Savettieri Italy 42 391 0.5× 947 1.3× 123 0.2× 710 1.2× 472 1.2× 146 4.9k

Countries citing papers authored by Daniel J. Brooks

Since Specialization
Citations

This map shows the geographic impact of Daniel J. Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Brooks more than expected).

Fields of papers citing papers by Daniel J. Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Brooks. The network helps show where Daniel J. Brooks may publish in the future.

Co-authorship network of co-authors of Daniel J. Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. Brooks. A scholar is included among the top collaborators of Daniel J. Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. Brooks. Daniel J. Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tokavanich, Nicha, Christian Castro, Yuki Arai, et al.. (2025). Control of alveolar bone development, homeostasis, and socket healing by salt-inducible kinases. Journal of Bone and Mineral Research. 40(5). 656–670.
2.
Hanlon, J. E., Mustafa Ünal, Daniel J. Brooks, et al.. (2025). Effect of type 1 and type 2 diabetes on human femoral trabecular bone composition, microarchitecture, and mechanical behavior. Bone. 200. 117588–117588.
3.
Brooks, Daniel J., Sun Park, Joseph O. Moore, et al.. (2024). Total body irradiation is associated with long-term deficits in femoral bone structure but not mechanical properties in male rhesus macaques. Scientific Reports. 14(1). 23379–23379. 1 indexed citations
4.
Lv, Zheng‐tao, Jiaming Zhang, Shuang Liang, et al.. (2023). Comparative study in estrogen-depleted mice identifies skeletal and osteocyte transcriptomic responses to abaloparatide and teriparatide. JCI Insight. 8(20). 6 indexed citations
5.
Mariani, John J., Cale Basaraba, Martina Pavlicová, et al.. (2023). Open label trial of lofexidine-assisted non-opioid induction onto naltrexone extended-release injection for opioid use disorder. The American Journal of Drug and Alcohol Abuse. 49(5). 618–629. 2 indexed citations
6.
Matar, Elie, Daniel J. Brooks, Simon J.G. Lewis, & Glenda M. Halliday. (2022). Limbic thalamus atrophy is associated with visual hallucinations in Lewy body disorders. Neurobiology of Aging. 112. 122–128. 6 indexed citations
7.
Levin, Frances R., John J. Mariani, Martina Pavlicová, et al.. (2021). Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial. Drug and Alcohol Dependence. 219. 108482–108482. 7 indexed citations
8.
Levin, Frances R., John J. Mariani, C. Jean Choi, et al.. (2021). Non-abstinent treatment outcomes for cannabis use disorder. Drug and Alcohol Dependence. 225. 108765–108765. 10 indexed citations
9.
Carvalho, Adriana Lelis, Daniel J. Brooks, Samantha Costa, et al.. (2021). TRPM8 modulates temperature regulation in a sex-dependent manner without affecting cold-induced bone loss. PLoS ONE. 16(6). e0231060–e0231060. 12 indexed citations
10.
Mesner, Larry D., Gina M. Calabrese, Daniel J. Brooks, et al.. (2021). Systems genetics in diversity outbred mice inform BMD GWAS and identify determinants of bone strength. Nature Communications. 12(1). 3408–3408. 32 indexed citations
11.
Chandler, Heidi, Daniel J. Brooks, Gary Hattersley, Mary Bouxsein, & Beate Lanske. (2019). Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia. Osteoporosis International. 30(8). 1607–1616. 20 indexed citations
12.
Levin, Frances R., C. Jean Choi, Martina Pavlicová, et al.. (2018). How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis. Drug and Alcohol Dependence. 188. 135–140. 19 indexed citations
13.
Reagan, Michaela R., Michelle M. McDonald, Rachael Terry, et al.. (2015). Anti-Sclerostin Treatment Prevents Multiple Myeloma Induced Bone Loss and Reduces Tumor Burden. Blood. 126(23). 119–119. 15 indexed citations
14.
Zhao, Jianjun, Jianhong Lin, Di Zhu, et al.. (2014). miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway. Cancer Research. 74(6). 1801–1813. 159 indexed citations
15.
Secora, Alex, et al.. (2010). A Comparison of Psychosocial and Cognitive Functioning Between Depressed and Non-Depressed Patients with Cannabis Dependence. Journal of Addictive Diseases. 29(3). 325–337. 9 indexed citations
16.
Brooks, Daniel J., et al.. (2009). Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia. Movement Disorders. 24(14). 2128–2135. 11 indexed citations
17.
Levin, Frances R., Suzette M. Evans, Daniel J. Brooks, & Fatima Garawi. (2006). Treatment of cocaine dependent treatment seekers with adult ADHD: Double-blind comparison of methylphenidate and placebo. Drug and Alcohol Dependence. 87(1). 20–29. 151 indexed citations
18.
Giladi, Nir, Olivier Rascol, Daniel J. Brooks, et al.. (2004). Rasagiline treatment can improve freezing of gait in advanced Parkinson's disease; a prospective randomised double blind, placebo and entacapone controlled study.. Movement Disorders. 19. 17 indexed citations
19.
Levin, Frances R., Suzette M. Evans, Suzanne K. Vosburg, et al.. (2004). Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addictive Behaviors. 29(9). 1875–1882. 97 indexed citations
20.
Bucknall, C., Daniel J. Brooks, P V Curry, et al.. (1988). Mianserin and trazodone for cardiac patients with depression. European Journal of Clinical Pharmacology. 33(6). 565–569. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026